中医药在肌少症中的作用:机制与治疗进展
肌少症以肌肉量、肌力和功能进行性丧失为特征,主要影响老年人,是多因素疾病。本综述总结中医药(草药、针灸、气功)治疗肌少症的临床研究与应用,探讨其潜在机制,并讨论未来研究方向与临床意义。
要点
- 中医药整合现代医学可能为老年肌少症患者提供更个性化治疗。
- 中医药在改善肌肉量、增强肌力、延缓衰老进程方面显示潜力。
- 肌少症发病涉及衰老、线粒体功能障碍、免疫炎症和肠道菌群失调。
核心结论
- 中医药(草药、针灸、气功)与现代医学整合,可能为老年肌少症患者提供更个性化治疗,并在改善肌肉量、增强肌力、延缓衰老及提高生活质量方面展现潜力。
研究设计与样本
- 本综述总结中医药治疗肌少症的临床研究与应用,探讨其潜在治疗机制,并讨论未来研究方向及临床相关性。
主要发现
- 肌少症发病涉及衰老相关过程、骨骼肌稳态失衡、线粒体功能障碍、免疫介导炎症和肠道菌群失调等多因素。
- 近期研究表明,中医药等传统疗法与现代医学治疗整合,可能为老年肌少症患者提供更个性化治疗。
- 中医药整合策略在改善肌肉量、增强肌力、延缓衰老进程及提高患者生活质量方面显示出可观潜力。
临床怎么用
- 临床可考虑将中医药(草药、针灸、气功)与现代医学治疗整合,为老年肌少症患者制定个性化方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sarcopenia is characterized by the progressive loss of muscle mass, strength, and function, predominantly affecting the elderly population, and has emerged as a significant public health concern in the context of global aging. Its pathogenesis is multifactorial, involving aging-related processes, imbalances in skeletal muscle homeostasis, mitochondrial dysfunction, immune-mediated inflammation, and gut microbiota dysbiosis. Recent studies suggest that traditional therapies, including traditional Chinese medicine (TCM)-such as herbal medicine, acupuncture, and qigong-when integrated with modern medical treatments, may offer a more personalized therapeutic approach for older adults with sarcopenia. This integrative strategy has demonstrated considerable potential to improve muscle mass, enhance strength, decelerate the aging process, and ultimately improve patients' quality of life. This review aims to summarize the clinical research and applications of TCM in sarcopenia management, explore the potential mechanisms underlying TCM's therapeutic effects, and discuss future research directions and their clinical relevance.
引用
- Yao J, Xia S. Exploring the role of traditional Chinese medicine in sarcopenia: mechanisms and therapeutic advances. Front Pharmacol. 2025. PMID: 40661078. doi:10.3389/fphar.2025.1541373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。